Lnc-EGFR specially binds to EGFR, enhances AP-1/NF-AT1/Foxp3 signaling, leading to Treg differentiation, and hepatocellular carcinoma progression. The gene discussed is NFATC2; the disease is hepatocellular carcinoma.